NASDAQ:HYFT • CA6026871054
The current stock price of HYFT is 1.305 USD. Today HYFT is up by 18.64%. In the past month the price decreased by -29.94%.
ChartMill assigns a technical rating of 0 / 10 to HYFT.
ChartMill assigns a fundamental rating of 2 / 10 to HYFT. HYFT has a bad profitability rating. Also its financial health evaluation is rather negative.
On December 15, 2025 HYFT reported an EPS of -0.07 and a revenue of 4.12M. The company missed EPS expectations (-37.25% surprise) and missed revenue expectations (-8.36% surprise).
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 212.64% is expected in the next year compared to the current price of 1.305.
For the next year, analysts expect an EPS growth of 16.7% and a revenue growth -33.14% for HYFT
Over the last trailing twelve months HYFT reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 57.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -114.31% | ||
| ROE | -168.52% | ||
| Debt/Equity | 0.18 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.22 | 189.444B | ||
| DHR | DANAHER CORP | 23.23 | 140.579B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.13 | 44.937B | ||
| A | AGILENT TECHNOLOGIES INC | 17.41 | 32.974B | ||
| WAT | WATERS CORP | 20.83 | 29.986B | ||
| IQV | IQVIA HOLDINGS INC | 13.55 | 29.973B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.39 | 25.384B | ||
| ILMN | ILLUMINA INC | 23.54 | 19.002B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 28.63 | 17.865B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.01 | 13.581B | ||
| RVTY | REVVITY INC | 16.47 | 10.298B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.353B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.6 | 8.713B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
IPO: 1987-01-30
MINDWALK HOLDINGS CORP
823 Congress Ave, Suite 300,,
Austin TEXAS US
Employees: 102
Phone: 18006204187
MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
The current stock price of HYFT is 1.305 USD. The price increased by 18.64% in the last trading session.
HYFT does not pay a dividend.
HYFT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
8 analysts have analysed HYFT and the average price target is 4.08 USD. This implies a price increase of 212.64% is expected in the next year compared to the current price of 1.305.
MINDWALK HOLDINGS CORP (HYFT) has a market capitalization of 60.93M USD. This makes HYFT a Micro Cap stock.
You can find the ownership structure of MINDWALK HOLDINGS CORP (HYFT) on the Ownership tab.